← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Chernett Jorey
10% Owner
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0002042077
Purchase history
- Companies traded
- 3
- Purchases · 12M
- 36
- Purchases · 24M
- 36
- Average purchase
- $263.4K
- Median purchase
- $157.0K
- Gross purchase value
- $9.5M
Companies: Airsculpt Technologies, Inc. | Neuronetics, Inc. | Oncology Institute, Inc. | Starling Oncology, Inc.
36 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-08-17 | Starling Oncology, Inc. | STLN | 10% Owner | $78.5K | Open filing |
| 2026-08-17 | Neuronetics, Inc. | STIM | 10% Owner | $44.2K | Open filing |
| 2026-07-22 | Oncology Institute, Inc. | TOI | 10% Owner | $94.9K | Open filing |
| 2026-07-15 | Neuronetics, Inc. | STIM | 10% Owner | $62.3K | Open filing |
| 2026-07-13 | Oncology Institute, Inc. | TOI | 10% Owner | $87.8K | Open filing |
| 2026-06-24 | Oncology Institute, Inc. | TOI | 10% Owner | $90.4K | Open filing |
| 2026-06-05 | Oncology Institute, Inc. | TOI | 10% Owner | $57.0K | Open filing |
| 2026-05-21 | Oncology Institute, Inc. | TOI | 10% Owner | $156.6K | Open filing |
| 2026-05-20 | Neuronetics, Inc. | STIM | 10% Owner | $117.0K | Open filing |
| 2026-05-20 | Oncology Institute, Inc. | TOI | 10% Owner | $122.7K | Open filing |
| 2026-05-13 | Neuronetics, Inc. | STIM | 10% Owner | $636.5K | Open filing |
| 2026-04-22 | Neuronetics, Inc. | STIM | 10% Owner | $309.0K | Open filing |
| 2026-04-20 | Airsculpt Technologies, Inc. | AIRS | 10% Owner | $101.6K | Open filing |
| 2026-04-15 | Airsculpt Technologies, Inc. | AIRS | 10% Owner | $52.0K | Open filing |
| 2026-04-13 | Oncology Institute, Inc. | TOI | 10% Owner | $62.0K | Open filing |
| 2026-04-08 | Airsculpt Technologies, Inc. | AIRS | 10% Owner | $175.8K | Open filing |
| 2026-04-06 | Airsculpt Technologies, Inc. | AIRS | 10% Owner | $253.8K | Open filing |
| 2026-03-30 | Neuronetics, Inc. | STIM | 10% Owner | $481.8K | Open filing |
| 2026-03-30 | Oncology Institute, Inc. | TOI | 10% Owner | $81.2K | Open filing |
| 2026-03-30 | Neuronetics, Inc. | STIM | 10% Owner | $675.0K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 3/36
- Large purchase ≥ $100k
- 24/36
- Cluster buying · 15D
- 0/36
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.